The risk of infections in hematologic patients treated with rituximab is not influenced by cumulative rituximab dosage - a single center experience
Crossref DOI link: https://doi.org/10.1186/1471-2334-14-364
Published Online: 2014-07-03
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nissen, Johanna C
Hummel, Margit
Brade, Joachim
Kruth, Jens
Hofmann, Wolf-Karsten
Buchheidt, Dieter
Reinwald, Mark
License valid from 2014-07-03
Article History
Received: 17 December 2013
Accepted: 18 June 2014
First Online: 3 July 2014